InhibrxInc Correlations
| INBX Stock | USD 34.14 0.05 0.15% |
The correlation of InhibrxInc is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as InhibrxInc moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if InhibrxInc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Average diversification
The correlation between InhibrxInc and NYA is 0.18 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding InhibrxInc and NYA in the same portfolio, assuming nothing else is changed.
InhibrxInc |
The ability to find closely correlated positions to InhibrxInc could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace InhibrxInc when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back InhibrxInc - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling InhibrxInc to buy it.
Moving together with InhibrxInc Stock
| 0.65 | VRAX | Virax Biolabs Group Fiscal Year End 12th of June 2024 | PairCorr |
| 0.72 | AQB | AquaBounty Technologies | PairCorr |
Moving against InhibrxInc Stock
| 0.65 | ACB | Aurora Cannabis Financial Report 12th of June 2024 | PairCorr |
| 0.64 | CGC | Canopy Growth Corp Earnings Call This Week | PairCorr |
| 0.58 | HCM | HUTCHMED DRC Earnings Call This Week | PairCorr |
| 0.46 | ERNA | Eterna Therapeutics | PairCorr |
| 0.43 | VALN | Valneva SE ADR | PairCorr |
Related Correlations Analysis
| 0.64 | 0.72 | -0.38 | 0.64 | 0.78 | TERN | ||
| 0.64 | 0.35 | -0.43 | 0.76 | 0.81 | ABOS | ||
| 0.72 | 0.35 | -0.36 | 0.25 | 0.58 | AMLX | ||
| -0.38 | -0.43 | -0.36 | -0.56 | -0.66 | ELVN | ||
| 0.64 | 0.76 | 0.25 | -0.56 | 0.8 | CMPX | ||
| 0.78 | 0.81 | 0.58 | -0.66 | 0.8 | VTYX | ||
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between InhibrxInc Stock performing well and InhibrxInc Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze InhibrxInc's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| TERN | 3.81 | (0.39) | 0.00 | (0.14) | 0.00 | 7.30 | 27.76 | |||
| ABOS | 3.21 | 0.11 | 0.02 | (0.48) | 4.02 | 7.66 | 23.58 | |||
| AMLX | 4.52 | (2.25) | 0.00 | (0.69) | 0.00 | 6.63 | 90.49 | |||
| ELVN | 4.79 | 0.73 | 0.17 | 0.29 | 4.16 | 9.52 | 50.27 | |||
| CMPX | 3.35 | (0.22) | 0.00 | (0.06) | 0.00 | 6.74 | 25.11 | |||
| VTYX | 5.25 | (0.22) | 0.00 | (0.06) | 0.00 | 18.85 | 47.38 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in InhibrxInc without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Odds Of Bankruptcy Now
Odds Of BankruptcyGet analysis of equity chance of financial distress in the next 2 years |
| All Next | Launch Module |
InhibrxInc Corporate Management
Elected by the shareholders, the InhibrxInc's board of directors comprises two types of representatives: InhibrxInc inside directors who are chosen from within the company, and outside directors, selected externally and held independent of InhibrxInc. The board's role is to monitor InhibrxInc's management team and ensure that shareholders' interests are well served. InhibrxInc's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, InhibrxInc's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Leah JD | Corporate VP | Profile | |
| Mark Lappe | Chairman, Founder | Profile | |
| Charbel PharmD | Vice Planning | Profile | |
| BS CPA | Chief Officer | Profile | |
| Jeffrey Jensen | Executive Officer | Profile | |
| Brendan Eckelman | Founder Officer | Profile | |
| Carlos Bais | Executive Sciences | Profile |
Already Invested in InhibrxInc?
The danger of trading InhibrxInc is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of InhibrxInc is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than InhibrxInc. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile InhibrxInc is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether InhibrxInc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of InhibrxInc's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Inhibrxinc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Inhibrxinc Stock: Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in InhibrxInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. For more information on how to buy InhibrxInc Stock please use our How to Invest in InhibrxInc guide.Note that the InhibrxInc information on this page should be used as a complementary analysis to other InhibrxInc's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Complementary Tools for InhibrxInc Stock analysis
When running InhibrxInc's price analysis, check to measure InhibrxInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InhibrxInc is operating at the current time. Most of InhibrxInc's value examination focuses on studying past and present price action to predict the probability of InhibrxInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InhibrxInc's price. Additionally, you may evaluate how the addition of InhibrxInc to your portfolios can decrease your overall portfolio volatility.
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |
Is InhibrxInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of InhibrxInc. If investors know InhibrxInc will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about InhibrxInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.44) | Revenue Per Share 0.036 | Quarterly Revenue Growth 4.964 | Return On Assets (0.57) | Return On Equity (20.31) |
The market value of InhibrxInc is measured differently than its book value, which is the value of InhibrxInc that is recorded on the company's balance sheet. Investors also form their own opinion of InhibrxInc's value that differs from its market value or its book value, called intrinsic value, which is InhibrxInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because InhibrxInc's market value can be influenced by many factors that don't directly affect InhibrxInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between InhibrxInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if InhibrxInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, InhibrxInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.